Accepted for Publication: December 10, 2021.
Published: February 23, 2022. doi:10.1001/jamanetworkopen.2022.0214
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Al Knawy B et al. JAMA Network Open.
Corresponding Author: Bandar Al Knawy, MD, King Saud Bin Abdulaziz University for Health Sciences, PO Box 22490, Riyadh 11426, Saudi Arabia (knawyb@ngha.med.sa).
Author Contributions: Dr Al Knawy had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Crooks.
Drafting of the manuscript: Al Knawy, McKillop, Abduljawad, Tarkoma, Bates, Lee, Kozlakidis, Crooks.
Critical revision of the manuscript for important intellectual content: McKillop, Abduljawad, Tarkoma, Adil, Schaper, Chee, Bates, Klag, Kozlakidis, Crooks, Rhee.
Administrative, technical, or material support: Al Knawy, Abduljawad, Tarkoma, Lee, Crooks.
Supervision: Al Knawy, Chee, Rhee.
Conflict of Interest Disclosures: Dr Bates reported receiving grants from EarlySense; personal fees from CDI Negev; equity from ValeraHealth, CLEW, MDClone, and FeelBetter; personal fees and grants from IBM Watson; and equity and personal fees from AESOP outside the submitted work. Dr Rhee reported beng a former IBM employee and current CVS Health employee during the conduct of the study. No other disclosures were reported.
Disclaimer: Although Dr Kozlakidis is identified as personnel of the International Agency for Research on Cancer/World Health Organization (IARC/WHO), the author alone is responsible for the views expressed in this article, which do not necessarily represent the decisions, policy, or views of the IARC/WHO.